Director, Corporate Development & Strategy

Superluminal Medicines is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. We are expanding the team of talented scientists who seek to build the future of small molecule drug discovery with creativity and innovation.

New Product Planning and Competitive Intelligence

• Define unmet need for each program through landscape assessments, treatment-paradigm analysis, KOL and payer input, and primary and secondary market research.
• Assess commercial opportunities, and build  revenue forecasts and scenarios by target patient populations, segments, and geographies.
• Build and maintain comprehensive competitive landscapes for each program: track and prioritize competitor programs, identify upcoming data readouts or regulatory events, and flag implications for our programs.
• Identify commercial risks, differentiation opportunities and key value drivers that may influence asset development and strategic decisions.
• Partner with program leads to translate unmet needs and competitive benchmarks into competitive TPPs, and use them to inform development plans, indication selection and sequencing, trial design, and go/no-go criteria.
• Engage external consultants, market research providers and industry experts, as appropriate, to support commercial assessments.

Portfolio Strategy & Business Planning

• Support the development and ongoing refinement of Superluminal’s enterprise strategy, strategic priorities, portfolio plan, and long-range plan
• Partner with scientific and functional leadership to develop and maintain a strategic view of the company's portfolio, including key milestones, risks, and opportunities 
• Work cross functionally to establish annual and multi-year business plans, ensuring alignment between corporate objectives, portfolio priorities and functional strategies.
• Develop business cases, financial analyses and scenario models to evaluate strategic alternatives, investment requirements and potential returns.
• Create clear decision frameworks for resource allocation, sequencing, partnering, financing, and organizational investment.

Corporate and Business Development

• Support Executive Committee and Board-level discussions on portfolio strategy, investment priorities and long-term value creation.
• Synthesize complex scientific, commercial and financial information into clear, actionable recommendations.
• Develop executive-level presentations, analyses and recommendations for leadership and Board discussions.
• Provide strategic and analytical support for business development opportunities, including potential partnerships, licensing and external asset evaluations.
• Create partner facing materials that connect platform advantages and program progress to collaboration and licensing opportunities. 
• Develop and maintain investor presentations, the corporate narrative, Q&A, and diligence materials that connect scientific progress to enterprise value.

• Bachelor's degree in Life Sciences, Business, Finance, Economics or a related discipline; 
• 8+ years of relevant experience in biotechnology or pharmaceuticals, with a background in commercial strategy, portfolio strategy, corporate development, business development, venture capital or life sciences management consulting.
• Experience within an emerging or early-stage biotechnology company.
• Experience conducting commercial feasibility assessments, market opportunity evaluations, competitive analyses and strategic assessments of drug development programs or pipeline assets.
• Experience in  drug discovery and development lifecycle, particularly early-stage development, and the ability to evaluate commercial opportunities in the context of evolving scientific and clinical data.
• Experience developing commercial assumptions, market models, financial analyses, business cases and scenario assessments to support strategic and investment decisions.
• Experience routinely briefing C-suite, Board members, or operating committee stakeholders on a regular cadence (e.g., quarterly risk reviews, monthly leadership briefings, or ongoing committee meetings).
• Experience authoring and presenting cross functional business cases and assessments that integrate clinical, financial, and regulatory data to drive go/no-go decisions. 
• Experience collaborating with scientific, commercial, finance and executive leadership teams.

• Master’s degree, PhD, or equivalent practical experience preferred.
• Direct experience structuring, negotiating, or drafting corporate development or partnering transactions within the biotechnology or pharmaceutical sector (e.g., licensing, asset acquisitions, or strategic alliances).

Superluminal Medicines is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status.